Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention

  Chronic Heart Failure

  Free Subscription


3 Am J Cardiol
4 Cardiovasc Res
1 Circ Cardiovasc Qual Outcomes
11 Circ Heart Fail
1 Circulation
2 Clin Cardiol
1 Eur Heart J
6 Eur J Heart Fail
1 Heart
7 Int J Cardiol
2 J Am Coll Cardiol
9 J Card Fail
1 J Cardiol
1 PLoS Comput Biol
1 PLoS One

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Am J Cardiol

  1. HABIB M, Adler A, Hoss S, Hanneman K, et al
    Temporal Changes in Cardiac Morphology and Its Relationship with Clinical Characteristics and Outcomes in Patients with Hypertrophic Cardiomyopathy.
    Am J Cardiol. 2022;176:125-131.
    PubMed         Abstract available

  2. AGUILAR-GALLARDO JS, Romeo FJ, Bhatia K, Correa A, et al
    Severe Obesity and Heart Failure.
    Am J Cardiol. 2022 Jun 12. pii: S0002-9149(22)00524.
    PubMed         Abstract available

  3. WESTIN OM, Butt JH, Gustafsson F, Kober L, et al
    Carpal Tunnel Syndrome in Patients Who Underwent Pacemaker Implantation and Relation to Amyloidosis, Heart Failure, and Mortality.
    Am J Cardiol. 2022 Jun 18. pii: S0002-9149(22)00536.
    PubMed         Abstract available

    Cardiovasc Res

  4. KUMARI R, Ranjan P, Suleiman ZG, Goswami SK, et al
    mRNA modifications in cardiovascular biology and disease: with a focus on m6A modification.
    Cardiovasc Res. 2022;118:1680-1692.
    PubMed         Abstract available

  5. JACKSON MR, Cox KD, Baugh SDP, Wakeen L, et al
    Discovery of a first-in-class inhibitor of sulfide:quinone oxidoreductase that protects against adverse cardiac remodelling and heart failure.
    Cardiovasc Res. 2022;118:1771-1784.
    PubMed         Abstract available

  6. PORTERO V, Nicol T, Podliesna S, Marchal GA, et al
    Chronically elevated branched chain amino acid levels are pro-arrhythmic.
    Cardiovasc Res. 2022;118:1742-1757.
    PubMed         Abstract available

  7. DHINGRA R, Kirshenbaum LA
    ULK1 mediated mitophagy prevents pathological cardiac remodelling and heart failure.
    Cardiovasc Res. 2022 Jun 21. pii: 6612712. doi: 10.1093.
    PubMed         Abstract available

    Circ Cardiovasc Qual Outcomes

  8. TRUSLOW JG, Goto S, Homilius M, Mow C, et al
    Cardiovascular Risk Assessment Using Artificial Intelligence-Enabled Event Adjudication and Hematologic Predictors.
    Circ Cardiovasc Qual Outcomes. 2022 Apr 28:101161CIRCOUTCOMES121008007.
    PubMed         Abstract available

    Circ Heart Fail

  9. MAURER MS, Dunnmon P, Fontana M, Quarta CC, et al
    Proposed Cardiac End Points for Clinical Trials in Immunoglobulin Light Chain Amyloidosis: Report From the Amyloidosis Forum Cardiac Working Group.
    Circ Heart Fail. 2022;15:e009038.
    PubMed         Abstract available

  10. KAYE DM, Vizi D, Graham S, Wang B, et al
    Physiologic Insights Into Long COVID Breathlessness.
    Circ Heart Fail. 2022;15:e009346.

  11. LUO F, Bu H
    Letter by Luo and Bu Regarding Article, "Comprehensive Proteomics Profiling Reveals Circulating Biomarkers of Hypertrophic Cardiomyopathy".
    Circ Heart Fail. 2022;15:e009499.

  12. SAVARIS SL, Chang IS, Wright SP, Mak S, et al
    Ramping Up the Pressure on the Right Ventricle.
    Circ Heart Fail. 2022;15:e009671.

  13. PREVIS MJ, O'Leary TS, Morley MP, Palmer BM, et al
    Defects in the Proteome and Metabolome in Human Hypertrophic Cardiomyopathy.
    Circ Heart Fail. 2022;15:e009521.
    PubMed         Abstract available

  14. YAN H, Yang W, Zhou F, Pan Q, et al
    Estrogen Protects Cardiac Function and Energy Metabolism in Dilated Cardiomyopathy Induced by Loss of Cardiac IRS1 and IRS2.
    Circ Heart Fail. 2022;15:e008758.
    PubMed         Abstract available

  15. BUTLER J, Talha KM, Aktas MK, Zareba W, et al
    Role of Implantable Cardioverter Defibrillator in Heart Failure With Contemporary Medical Therapy.
    Circ Heart Fail. 2022 Jun 21:CIRCHEARTFAILURE122009634.
    PubMed         Abstract available

  16. LEWSEY SC, Hays AG, Schar M, Bonanno G, et al
    Nitric Oxide-Mediated Coronary Endothelial Function Is Impaired in Patients With Heart Failure With Preserved Ejection Fraction.
    Circ Heart Fail. 2022 Jun 21:101161CIRCHEARTFAILURE122009582.

  17. LIANG LW, Shimada YJ
    Response by Liang and Shimada to Letter Regarding Article "Comprehensive Proteomics Profiling Reveals Circulating Biomarkers of Hypertrophic Cardiomyopathy".
    Circ Heart Fail. 2022;15:e009568.

  18. ZHOU Z, Nelson M, Ernst ME, Reid C, et al
    Does Aspirin Prevent Incident Heart Failure in Healthy Older Adults? Examining the Evidence From the ASPREE Trial.
    Circ Heart Fail. 2022;15:e009511.

  19. ROSENZWEIG R, Kumar V, Gupta S, Bermeo-Blanco O, et al
    Estrogen Receptor-beta Agonists Modulate T-Lymphocyte Activation and Ameliorate Left Ventricular Remodeling During Chronic Heart Failure.
    Circ Heart Fail. 2022 Jun 22:CIRCHEARTFAILURE121008997.
    PubMed         Abstract available


  20. DELLA BELLA P, Baratto F, Vergara P, Bertocchi P, et al
    Does Timing of Ventricular Tachycardia Ablation Affect Prognosis in Patients With an Implantable Cardioverter Defibrillator? Results From the Multicenter Randomized PARTITA Trial.
    Circulation. 2022 Apr 3. doi: 10.1161/CIRCULATIONAHA.122.059598.
    PubMed         Abstract available

    Clin Cardiol

  21. SCIRICA BM, Im K, Murphy SA, Kuder JF, et al
    Re-adjudication of the Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS) with study-level meta-analysis of hospitalization for heart failure from cardiovascular outcomes trials with dipeptidyl peptidase-4 (DPP-4) inhibitors.
    Clin Cardiol. 2022 Jun 17. doi: 10.1002/clc.23844.
    PubMed         Abstract available

  22. NAKAGAWA Y, Imamura T
    Detailed association between the etiologies of heart failure and occurrence of sleep-disordered breathing.
    Clin Cardiol. 2022 Jun 22. doi: 10.1002/clc.23875.

    Eur Heart J

  23. Erratum to: Influence of atrial fibrillation on efficacy and safety of omecamtiv mecarbil in heart failure: the GALACTIC-HF trial.
    Eur Heart J. 2022 Jun 18. pii: 6610027. doi: 10.1093.

    Eur J Heart Fail

  24. COATS A, Abraham WT, Zile MR, Lindenfeld JA, et al
    Baroreflex activation therapy with the barostim device in patients with heart failure with reduced ejection fraction: A patient level meta-analysis of randomized controlled trials.
    Eur J Heart Fail. 2022 Jun 17. doi: 10.1002/ejhf.2573.
    PubMed         Abstract available

    Moving beyond the Vasodilator Model in Heart Failure with reduced Ejection Fraction - Lessons from Sildenafil.
    Eur J Heart Fail. 2022 Jun 19. doi: 10.1002/ejhf.2582.

  26. VUKADINOVIC D, Abdin A, Anker SD, Rosano GM, et al
    Side effects and treatment initiation barriers of SGLT2 inhibitors in heart failure: A systematic review and meta-analysis.
    Eur J Heart Fail. 2022 Jun 22. doi: 10.1002/ejhf.2584.
    PubMed         Abstract available

  27. MULLENS W, Dauw J, Martens P, Meekers E, et al
    Acetazolamide in Decompensated Heart Failure with Volume Overload trial (ADVOR): Baseline Characteristics.
    Eur J Heart Fail. 2022 Jun 22. doi: 10.1002/ejhf.2587.
    PubMed         Abstract available

  28. INCIARDI RM, Pagnesi M, Lombardi CM, Anker SD, et al
    Clinical implications of left atrial changes after optimization of medical therapy in patients with heart failure.
    Eur J Heart Fail. 2022 Jun 24. doi: 10.1002/ejhf.2593.
    PubMed         Abstract available

  29. HARIHARAPUTHIRAN S, Peng Y, Ngo L, Ali A, et al
    Long-term Survival and Life Expectancy Following an Acute Heart Failure Hospitalisation in Australia and New Zealand.
    Eur J Heart Fail. 2022 Jun 24. doi: 10.1002/ejhf.2595.
    PubMed         Abstract available


  30. KUMAR R, Rai N, Ahmed AS
    Right heart failure in a young man.
    Heart. 2022;108:1120-1160.

    Int J Cardiol

  31. KHAZAEI S, Khazaei M
    Comment on: Prognostic implications of staging cardiac remodeling in patients undergoing cardiac resynchronization therapy.
    Int J Cardiol. 2022;362:152.

  32. COWIE MR, Mourilhe-Rocha R, Chang HY, Volterrani M, et al
    The impact of the COVID-19 pandemic on heart failure management: Global experience of the OPTIMIZE heart failure care network.
    Int J Cardiol. 2022 Jun 21. pii: S0167-5273(22)00922.
    PubMed         Abstract available

  33. EPSTEIN E, Schale S, Brambatti M, You H, et al
    Impact of Transitioning Patients to Oral Diuretics 24 Hours Before Discharge from Heart Failure Hospitalization on 30 Day Outcomes.
    Int J Cardiol. 2022 Jun 20. pii: S0167-5273(22)00930.
    PubMed         Abstract available

  34. CANEPA M, Leporatti L, Persico L, Ameri P, et al
    Frequency, characteristics and prognostic impact of hospital readmissions in elderly patients with heart failure: A population study from 2013 to 2017 in Liguria, Northern Italy.
    Int J Cardiol. 2022 Jun 18. pii: S0167-5273(22)00951.
    PubMed         Abstract available

  35. JOURY A, Ventura H, Krim SR
    Biomarkers in heart failure: Relevance in the clinical practice.
    Int J Cardiol. 2022 Jun 15. pii: S0167-5273(22)00935.
    PubMed         Abstract available

  36. DE LANGE I, Petersen TB, de Bakker M, Akkerhuis KM, et al
    Heart failure subphenotypes based on repeated biomarker measurements are associated with clinical characteristics and adverse events (Bio-SHiFT study).
    Int J Cardiol. 2022 Jun 14. pii: S0167-5273(22)00919.
    PubMed         Abstract available

  37. BURRI H
    Electrical remodeling and super-response with biventricular and conduction system pacing: Can cardiac resynchronization therapy be curative?
    Int J Cardiol. 2022;362:83-84.

    J Am Coll Cardiol

  38. WASFY JH, O'Kelly AC
    Value-Based Prices Could Establish Common Ground on Heart Failure Drug Pricing and Coverage.
    J Am Coll Cardiol. 2022;79:2526-2528.

  39. FARIDI KF, Dayoub EJ, Ross JS, Dhruva SS, et al
    Medicare Coverage and Out-of-Pocket Costs of Quadruple Drug Therapy for Heart Failure.
    J Am Coll Cardiol. 2022;79:2516-2525.
    PubMed         Abstract available

    J Card Fail

  40. BATRA J, Rosenblum H, Cappelli F, Zampieri M, et al
    Racial Differences in Val122Ile-Associated Transthyretin Cardiac Amyloidosis.
    J Card Fail. 2022;28:950-959.
    PubMed         Abstract available

  41. FECHT D, Chadeau-Hyam M, Owen R, Gregson J, et al
    Exposure to Elevated Nitrogen Dioxide Concentrations and Cardiac Remodeling in Patients With Dilated Cardiomyopathy.
    J Card Fail. 2022;28:924-934.
    PubMed         Abstract available

    Biology or Disparity? Untangling Racial Differences in Val122Ile Transthyretin Cardiac Amyloidosis.
    J Card Fail. 2022;28:960-962.

  43. PARENT B, Yang YT, Caplan A
    Should Patients Who Refuse COVID Vaccination Be Denied Transplantation Eligibility?
    J Card Fail. 2022;28:1042-1043.

  44. GARRY DJ, Kamdar F, Alexy T
    Dystrophic Cardiomyopathy and the Need for Cardiovascular Care.
    J Card Fail. 2022;28:1040-1041.

  45. TOWNSEND M, Karamlou T, Boyle G, Daly K, et al
    Waitlist Outcomes for Children With Congenital Heart Disease: Lessons Learned From Over 5000 Heart Transplant Listings in the United States.
    J Card Fail. 2022;28:982-990.
    PubMed         Abstract available

  46. BHARDWAJ A, Ramu B, Blumer V, Cogswell R, et al
    Women Empowering Women in Heart Transplantation and Mechanical Circulatory Support.
    J Card Fail. 2022;28:1031-1034.

    The Team is Larger Than I Thought.
    J Card Fail. 2022;28:1044-1045.

  48. LALA A, Mentz RJ
    Advancing Our Common Purpose Through "Coopetition".
    J Card Fail. 2022;28:881-882.

    J Cardiol

  49. AMISAKI R, Kato M, Fujiyama M, Matsuda E, et al
    Difficulty initiating sleep in patients with heart failure: Impact of left atrial pressure.
    J Cardiol. 2022 Jun 17. pii: S0914-5087(22)00136.
    PubMed         Abstract available

    PLoS Comput Biol

  50. HERNANDEZ MESA M, van den Brink J, Louch WE, McCabe KJ, et al
    Nanoscale organization of ryanodine receptor distribution and phosphorylation pattern determines the dynamics of calcium sparks.
    PLoS Comput Biol. 2022;18:e1010126.
    PubMed         Abstract available

    PLoS One

  51. SANDSTEDT M, Vukusic K, Ulfenborg B, Jonsson M, et al
    Human intracardiac SSEA4+CD34 cells show features of cycling, immature cardiomyocytes and are distinct from Side Population and C-kit+CD45- cells.
    PLoS One. 2022;17:e0269985.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Chronic Heart Failure is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.